Valuation: AbClon Inc.

Market Cap 545B 383M 332M 311M 285M 537M 36.48B 544M 3.64B 1.43B 18.23B 1.44B 1.41B 60.67B P/E 2024
-14.5x
P/E 2025 -43.5x
Enterprise Value 507B 356M 309M 290M 265M 500M 33.94B 507M 3.39B 1.33B 16.96B 1.34B 1.31B 56.44B EV / Sales 2024
103x
EV / Sales 2025 164x
Free-Float
80.08%
Yield 2024 *
-
Yield 2025 -
1 day+4.20%
1 week+57.99%
Current month+38.58%
1 month+6.43%
3 months-40.72%
6 months-54.04%
Current year-35.76%
1 week 19,220
Extreme 19220
28,500
1 month 16,250
Extreme 16250
28,500
Current year 16,250
Extreme 16250
95,800
1 year 9,770
Extreme 9770
95,800
3 years 6,810
Extreme 6810
95,800
5 years 6,810
Extreme 6810
95,800
10 years 6,810
Extreme 6810
95,800
Manager TitleAgeSince
Chief Executive Officer 63 24/06/2010
Director of Finance/CFO 59 27/03/2024
Chief Tech/Sci/R&D Officer 57 28/03/2023
Director TitleAgeSince
Director/Board Member 63 -
Director/Board Member 62 28/03/2021
Director/Board Member 57 28/03/2023
Change 5-day change 1-year change 3-year change Capi.($)
+4.20%+57.99%+151.15%+51.75% 383M
+0.47%+2.41%+39.51%+0.81% 77.1B
+0.84%+1.93%+23.14%+184.28% 49.43B
+1.54%-0.85%-4.49%+23.71% 49.27B
-0.13%+7.42%-50.22%-49.58% 44.59B
-0.42%+1.87%+61.83%-23.78% 30.48B
+0.97%+0.19%+53.13%+84.49% 24B
+4.11%+1.90%+109.92%-44.80% 21.5B
+4.29%+9.40%+3.77%+226.51% 20.18B
+2.60%-2.59%+67.30%+126.48% 16.29B
Average +1.90%+3.83%+45.51%+57.99% 33.32B
Weighted average by Cap. +1.21%+1.52%+25.46%+45.38%

Financials

2024 2025
Net sales 2.34B 1.65M 1.43M 1.34M 1.22M 2.31M 157M 2.34M 15.64M 6.14M 78.3M 6.18M 6.04M 261M 4.71B 3.31M 2.88M 2.69M 2.46M 4.65M 316M 4.71M 31.51M 12.37M 158M 12.44M 12.17M 525M
Net income -16.3B -11.46M -9.95M -9.31M -8.52M -16.08M -1.09B -16.29M -109M -42.76M -545M -43.03M -42.1M -1.82B -17.91B -12.59M -10.93M -10.23M -9.36M -17.67M -1.2B -17.9M -120M -46.97M -599M -47.27M -46.24M -1.99B
Net Debt -4.61B -3.24M -2.81M -2.63M -2.41M -4.55M -309M -4.61M -30.82M -12.1M -154M -12.17M -11.91M -514M -37.93B -26.66M -23.14M -21.67M -19.82M -37.42M -2.54B -37.91M -253M -99.48M -1.27B -100M -97.94M -4.22B
Logo AbClon Inc.
AbClon Inc is a Korea-based company principally engaged in the development, manufacture and distribution of antibody drug. The Company developed a bio synergy antibody, a therapeutic antibody for a new mechanism that is different from conventional therapeutic agents, and is based on the YPLUS and AffiMab platforms. The company's products include AC101, AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103. The Company distributes its products within domestic market and to overseas markets.
Employees
-
Date Price Change Volume
07/08/26 ₩28,000.00 +2.56% 148,989
06/08/26 ₩27,300.00 +4.20% 226,005
05/08/26 ₩26,200.00 -1.13% 184,558
04/08/26 ₩26,500.00 +20.73% 499,801
03/08/26 ₩21,950.00 +11.42% 146,070
  1. Stock Market
  2. Stocks
  3. A174900 Stock